Trials / Not Yet Recruiting
Not Yet RecruitingNCT06900348
Prostate Specific Antigen Levels of Individuals Living in Rural Areas
Prostate Specific Antigen Levels and Its Relationship With Some Characteristics in Individuals Living in Rural Areas: A Cross-Sectional Study
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 308 (estimated)
- Sponsor
- Suleyman Demirel University · Academic / Other
- Sex
- Male
- Age
- 55 Years
- Healthy volunteers
- Accepted
Summary
It was planned in cross-sectional design in order to determine the specific prostate antigen level and some characteristics and the relationship evaluations and prostate specific antigen formation in individuals living in rural areas. It was planned to perform socio-demographic information formula, form including social information of health, prostate specific antigen test in the project data recording.
Detailed description
It was planned in a cross-sectional design to evaluate the prostate specific antigen level and its relationship with some characteristics in elderly individuals living in rural areas and to determine the prostate specific antigen level. The research area of the project consists of 8 villages. In the collection of project data, it was planned to conduct a socio-demographic feature information form, a form including social determinants of health, and a prostate specific antigen test. This planned project is the first research to be conducted in our country in terms of determining risky groups, ensuring randomness in participants, and sampling method for universe representation. In addition, screening the rural area, which is disadvantaged in terms of socio-economic and demographic aspects, and preferring elderly individuals constitute the steps taken to ensure health equality of the disadvantaged group in terms of health service transportation opportunities.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | PSA-Activated PSA-PAH1 | Intravenous blood sample |
Timeline
- Start date
- 2025-03-25
- Primary completion
- 2025-07-30
- Completion
- 2025-08-30
- First posted
- 2025-03-28
- Last updated
- 2025-03-30
Source: ClinicalTrials.gov record NCT06900348. Inclusion in this directory is not an endorsement.